Friday, July 10, 2026

Drug profile · INN

oestrogens conjugated

oestrogens conjugated (DUAVIVE) is a estrogen receptor agonist.

EMA: approved Genito-urinary system and sex hormones (G03) G03CC07
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — oestrogens conjugated
Class
Genito-urinary system and sex hormones (G03)
Route
Patents
0
Programs
0
Data quality
0.83

Quick answer

oestrogens conjugated (DUAVIVE) is a estrogen receptor agonist.

Key facts

INN oestrogens conjugated
Brand DUAVIVE
Mechanism Estrogen receptor agonist
Target Estrogen receptor
Therapeutic class Genito-urinary system and sex hormones (G03)
ATC code G03CC07

Mechanism of action

Estrogen receptor agonist

Primary target: Estrogen receptor

Approval history

Authority Status Date
EMA approved

Related & competitor drugs

  1. apomorphine Genito-urinary system and sex hormones (G04)
  2. estradiol Estrogen receptor alpha agonist
  3. estradiol valerate Estrogen receptor alpha agonist
  4. estrogens, conjugated synthetic a Estrogen receptor agonist
  5. estropipate Estrogen receptor alpha agonist
  6. ethinyl estradiol Estrogen receptor alpha agonist

Frequently asked questions

What is oestrogens conjugated?

oestrogens conjugated (DUAVIVE) is a estrogen receptor agonist.

What is the brand name for oestrogens conjugated?

DUAVIVE is a marketed brand name for oestrogens conjugated. Check FDA Drugs@FDA for the current US label holder and prescribing information.